PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22842919-6	2012	Ang II caused the contraction of HASMCs; this effect was reversed by Ang-(1-7).	hasmcs	33-39	angiotensinogen	Homo sapiens	0-6	
22842919-8	2012	Furthermore, Y-27632, an inhibitor of ROCK2, attenuated the Ang II-induced contraction of HASMCs by blocking the RhoA/ROCK2 signaling pathway which is involved in this contraction, and thus may be a major regulator involved in the basal maintenance of contractility in HASMCs.	hasmcs	90-96	angiotensinogen	Homo sapiens	60-66	
19011954-7	2009	Transfecting HASMCs with small interfering RNA (siRNA) to silence ERK5 inhibited Ang II-induced cell hypertrophy.	hasmcs	13-19	angiotensinogen	Homo sapiens	81-87	
8230860-4	1993	The addition of AII to HASMCs induced a rapid, transient increase in intracellular free Ca2+ concentration followed by a lower, sustained phase.	hasmcs	23-29	angiotensinogen	Homo sapiens	16-19	
8230860-6	1993	These results revealed AII receptors in HASMCs to be of the type 1 receptor subtype, which induce Ca2+ mobilization mainly from intracellular Ca2+ stores.	hasmcs	40-46	angiotensinogen	Homo sapiens	23-26	
16713603-7	2006	SalB also significantly inhibited angiotensin II or H2O2-induced MMP-2 mRNA and protein expression and gelatinolytic activity in HASMCs.	hasmcs	129-135	angiotensinogen	Homo sapiens	34-48	
30258282-8	2018	Plasma from AD patients further increased Bax mRNA levels but decreased Bcl2 and alpha-SMA mRNA levels in Ang II-treated HASMCs.	hasmcs	121-127	angiotensinogen	Homo sapiens	106-112